Furthermore, NIK overactivation was observed to have a role in cell survival and proliferation in pancreatic cancer cell lines, implicating NIK as therapeutic target for growth inhibition [99]. The gene discussed is MAP3K14; the disease is familial pancreatic carcinoma.